La cadena de opciones muestra datos clave de las opciones de acciones de FormFactor a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para FormFactor..

FormFactor (NASDAQ:FORM) Bolsa, Cadena de Opciones

FormFactor

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

APPS

AVGR

BBAI

COHR

DGLY

FORM

MBRX

MTRX

PTIX

RANI

RXRX

SBET

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SLXN

SWKS

Coherent sorprende con sus resultados trimestrales y dispara sus acciones un 15,5%. ¿Qué otras empresas se mueven en el premercado de EE.UU.?

Acciones de Coherent (COHR) se disparan un 15%; 20 acciones que se mueven en el premercado de EE.UU.

FormFactor Inc

FORMATION METALS INC by FORMATION METALS INC

FORMOSA PROSONIC INDSTS by Formosa Prosonic Industries Bhd

FORMATION MINERALS INC by Formation Minerals, Inc.

Formation Minerals Inc

Formcap Corp

Formidable ETF

Formula Systems (1985) Ltd. - American Depositary Shares

Formula Systems (1985) Ltd

FormFactor To Integrate Delft Circuits' Cri/oFlex Portfolio Into FormFactor's Cryogenic Test Systems

WIIM

AOSL

ENTG

KLAC

LRCX

MTSI

OLED

QCOM

RMBS

SMTC

Shares of semiconductor stocks are trading lower after a Wall Street Journal report revealed that Chinese buyers have been ordering Nvidia chips despite U.S. restrictions. Additionally, President Trump confirmed Mar. 4 tariffs, which could drive further trade uncertainty.

ACMR, ALAB, AMAT, AMBA, AMD, AMKR, AOSL, ARM, ARQQ, ASML, ASX, ATO, CAMT, CRDO, ENTG, FORM, HIMX, ICHR, INTC, KLAC, KLIC, LAES, LRCX, MKSI, MTSI, MU, MXL, NN, NVDA, NVMI, NVTS, ONDS, ONTO, QUIK, RGTI, RMBS, SITM, SKYT, SMH, SMTC, SOXX, STM, TSEM, TSM, UCTT, VUZI, WOLF

ALAB

AMAT

AMBA

AMCR

AMKR

ARQQ

ASML

CAMT

CRDO

HIMX

ICHR

KLIC

MKSI

NVDA

NVMI

NVTS

ONDS

ONTO

QUIK

RGTI

SITM

SKYT

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

TSEM

UCTT

VUZI

Shares of semiconductor companies are trading lower in sympathy with Nvidia, which reversed amid a possible selloff after reporting Q4 financial results.

ACMR

INTC

LAES

WOLF

Shares of semiconductor companies are trading higher in anticipation of Nvidia's Q4 earnings which are scheduled to be reported after hours today. Additionally, large AI investment announcements from Apple and Meta this week may be buoying the industry.

<h3>Gainers</h3>
<ul>
<li>Digital Turbine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPS#NASDAQ">APPS</a>) stock increased by 25.5% to $3.19 during Thursday's pre-market session. The company's market cap stands at $330.7 million. As per the news, the Q3 earnings report came out yesterday. </li>
<li>TTM Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) shares rose 21.06% to $30.0. The market value of their outstanding shares is at $3.0 billion. As per the press release, Q4 earnings came out yesterday. </li>
<li>SEALSQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAES#NASDAQ">LAES</a>) stock moved upwards by 17.01% to $4.47. The market value of their outstanding shares is at $351.1 million. </li>
<li>Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) shares increased by 15.43% to $104.01. The market value of their outstanding shares is at $16.0 billion. As per the press release, Q2 earnings came out yesterday. </li>
<li>Atomera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOM#NASDAQ">ATOM</a>) stock increased by 13.39% to $10.5. The company's market cap stands at $302.1 million. </li>
<li>Castellum (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CTM#AMEX">CTM</a>) stock rose 11.37% to $0.85. The market value of their outstanding shares is at $65.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Skyworks Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) shares declined by 28.0% to $62.7 during Thursday's pre-market session. The company's market cap stands at $10.0 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>Impinj (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) shares decreased by 21.94% to $99.19. The company's market cap stands at $2.7 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) shares declined by 21.41% to $32.32. The company's market cap stands at $2.5 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Alpha &amp; Omega (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOSL#NASDAQ">AOSL</a>) stock decreased by 11.8% to $38.22. The company's market cap stands at $1.1 billion. As per the news, the Q2 earnings report came out yesterday. </li>
<li>ePlus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUS#NASDAQ">PLUS</a>) stock fell 8.57% to $74.0. The market value of their outstanding shares is at $1.9 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Arrow Electronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARW#NYSE">ARW</a>) stock declined by 8.37% to $105.3. The market value of their outstanding shares is at $5.5 billion. As per the press release, Q4 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATOM

PLUS

TTMI

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

In the preceding three months, 4 analysts have released ratings for FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>), presenting a wide array of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $42.5, a high estimate of $51.00, and a low estimate of $34.00. Experiencing a 17.48% decline, the current average is now lower than the previous average price target of $51.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1738872069_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The perception of FormFactor by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian Chin</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$42.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Vedvati Shrotre</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$43.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Craig Ellis</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$34.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$51.00</td>
<td>$44.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to FormFactor. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of FormFactor compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for FormFactor's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of FormFactor's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/FORM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on FormFactor analyst ratings.</a>
<h2>Delving into FormFactor's Background</h2>
FormFactor Inc designs, develops, manufactures, sells, and supports semiconductor probe card products. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.
<h3>Unraveling the Financial Story of FormFactor</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: FormFactor displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 21.18%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: FormFactor's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 9.01%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): FormFactor's ROE stands out, surpassing industry averages. With an impressive ROE of 1.97%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): FormFactor's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.62% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.04.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

A Glimpse Into The Expert Outlook On FormFactor Through 4 Analysts

Stifel analyst Brian Chin maintains FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) with a Hold and lowers the price target from $48 to $42.

Price Target

Stifel Maintains Hold on FormFactor, Lowers Price Target to $42

Evercore ISI Group analyst Vedvati Shrotre maintains FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) with a In-Line and lowers the price target from $50 to $43.

Evercore ISI Group Maintains In-Line on FormFactor, Lowers Price Target to $43

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Evercore ISI Group analyst Shweta Khajuria downgraded the rating for Match Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) from Outperform to In-Line and maintained the price target of $35. Match Group shares closed at $33.58 on Wednesday. <a href="https://www.benzinga.com/quote/MTCH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho analyst Vijay Rakesh downgraded Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) from Outperform to Neutral and lowered the price target from $105 to $62. Skyworks Solutions shares closed at $87.08 on Wednesday. <a href="https://www.benzinga.com/quote/SWKS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Robbie Marcus downgraded CONMED Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNMD#NYSE">CNMD</a>) from Overweight to Neutral and cut the price target from $85 to $70. Conmed shares closed at $74.00 on Wednesday. <a href="https://www.benzinga.com/quote/CNMD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B. Riley Securities analyst Craig Ellis downgraded the rating for FormFactor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) from Buy to Neutral and lowered the price target from $64 to $34. FormFactor shares closed at $41.12 on Wednesday. <a href="https://www.benzinga.com/quote/FORM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Alex Scott downgraded Voya Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOYA#NYSE">VOYA</a>) from Overweight to Equal-Weight and maintained the price target of $75. Voya Financial shares closed at $72.22 on Wednesday. <a href="https://www.benzinga.com/quote/VOYA/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying MTCH stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06063625/image-54-1024x576.png" alt="" class="wp-image-769131" style="width:601px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06063625/image-54-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06063625/image-54-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06063625/image-54-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/06063625/image-54.png 1106w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43493237/jim-cramer-this-health-care-stock-is-a-winner-buy-bitcoin-instead-of-coinbase">Jim Cramer: This Health Care Stock Is A &#8216;Winner,&#8217; Buy Bitcoin Instead Of Coinbase</a></li>
</ul>

Downgrades

CNMD

MTCH

VOYA

This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

U.S. stock futures were higher this morning, with the Dow Jones futures gaining around 100 points on Thursday.
Shares of Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) fell sharply in today's pre-market trading after the company said that it expects $5 billion to $5.5 billion in losses in its EV segment this year, in line with the loss <a href="https://www.benzinga.com/tech/25/02/43522408/ford-slides-5-pre-market-after-disappointing-outlook-high-loss-from-ev-segment-in-2024">recorded last year</a>.
Ford said it sees full-year 2025 adjusted EBIT in a range of $7 billion to $8.5 billion, adjusted free cash flow in a range of $3.5 billion to $4.5 billion, and capital spending in a range of $8 billion to $9 billion.
Meanwhile, Ford reported upbeat fourth-quarter financial results on Wednesday.
Ford Motor shares dipped 6.1% to $9.40 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) dipped 29.2% to $61.65 in pre-market trading after the company issued second-quarter adjusted EPS guidance below estimates..</li>
<li>FormFactor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) fell 27.7% to $29.78 in today's pre-market trading after the company reported worse-than-expected fourth-quarter adjusted EPS results and issued cirst-quarter guidance below estimates.</li>
<li>Matrix Service Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTRX#NASDAQ">MTRX</a>) shares fell 26.1% to $10.38 in pre-market trading after the company reported second-quarter financial results and cut its FY25 sales guidance below estimates.</li>
<li>SunCar Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDA#NASDAQ">SDA</a>) fell 18.3% to $6.90 in pre-market trading after the company reported the pricing of $50 million follow-on public offering of class a ordinary shares.   </li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) fell 16.6% to $25.80 in pre-market trading. Symbotic reported quarterly losses of three cents per share which missed the analyst consensus estimate for losses of two cents. Quarterly revenue of $486.69 million also missed the analyst consensus estimate of $490.98 million.</li>
<li>Mach Natural Resources LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNR#NYSE">MNR</a>) declined 6.9% to $16.00 in pre-market trading as the company announced the launch of 12 million common unit offering.</li>
<li>Mineralys Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLYS#NASDAQ">MLYS</a>) fell 5.5% to $9.70 in pre-market trading. Mineralys Therapeutics will report its financial results from the fourth quarter, before the opening bell on Wednesday, Feb. 12.</li>
<li>Hologic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLX#NASDAQ">HOLX</a>) slipped 4.9% to $69.22 in pre-market trading following quarterly results.</li>
<li>QUALCOMM Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) fell 4.7% to $167.50 in pre-market trading following first-quarter results.</li>
<li>Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) fell 4.2% to $166.06 in pre-market trading. Arm Holdings reported better-than-expected third-quarter financial results for fiscal year 2025 after the market closed on Wednesday. Arm said it expects fourth-quarter revenue of $1.175 billion to $1.275 billion. The company anticipates fourth-quarter adjusted earnings of 48 cents to 56 cents per share. The company also narrowed its full-year guidance.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43493237/jim-cramer-this-health-care-stock-is-a-winner-buy-bitcoin-instead-of-coinbase">Jim Cramer: This Health Care Stock Is A &#8216;Winner,&#8217; Buy Bitcoin Instead Of Coinbase</a></li>
</ul>

HOLX

MLYS

Ford, Skyworks Solutions, FormFactor And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Needham analyst Charles Shi reiterates FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) from Hold to Hold.

Reiteration

Needham Reiterates Hold on FormFactorto Hold

<h3>Gainers</h3>
<ul>
<li>Digital Turbine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPS#NASDAQ">APPS</a>) shares rose 26.4% to $3.21 during Thursday's pre-market session. The market value of their outstanding shares is at $332.9 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) shares rose 13.31% to $102.1. The market value of their outstanding shares is at $15.7 billion. As per the press release, Q2 earnings came out yesterday. </li>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) stock moved upwards by 9.63% to $0.09. The company's market cap stands at $1.9 million. </li>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) stock rose 9.3% to $0.3. The company's market cap stands at $7.7 million. </li>
<li>Airgain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRG#NASDAQ">AIRG</a>) stock rose 8.42% to $7.59. The company's market cap stands at $86.1 million. </li>
<li>Brand Engagement Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares moved upwards by 7.69% to $0.42. The market value of their outstanding shares is at $15.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Skyworks Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) stock decreased by 29.5% to $61.4 during Thursday's pre-market session. The market value of their outstanding shares is at $9.8 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) stock declined by 28.75% to $29.3. The market value of their outstanding shares is at $2.2 billion. The company's, Q4 earnings came out yesterday. </li>
<li>Impinj (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) shares declined by 23.66% to $97.0. The market value of their outstanding shares is at $2.7 billion. As per the press release, Q4 earnings came out yesterday. </li>
<li>Alpha &amp; Omega (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOSL#NASDAQ">AOSL</a>) shares decreased by 12.84% to $37.77. The company's market cap stands at $1.0 billion. As per the press release, Q2 earnings came out yesterday. </li>
<li>Alpha Modus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMOD#NASDAQ">AMOD</a>) shares fell 5.49% to $2.24. The company's market cap stands at $29.5 million. </li>
<li>Cloudastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSAI#NASDAQ">CSAI</a>) stock declined by 5.31% to $7.85. The market value of their outstanding shares is at $114.5 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRG

AMOD

BNAI

CSAI

Shares of Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) rose sharply in pre-market trading after the company reported <a href="https://www.benzinga.com/quote/COHR/earnings">better-than-expected second-quarter financial results.</a>
Coherent reported quarterly earnings of 95 cents per share which beat the analyst consensus estimate of 69 cents per share.&nbsp; The company reported quarterly sales of $1.44 billion which beat the analyst consensus estimate of $1.37 billion.
Coherent shares jumped 15.5% to $104.04 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>SharpLink Gaming, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) gained 43.5% to $0.6031 in pre-market trading.</li>
<li>Rani Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) rose 28.5% to $1.85 in pre-market trading after the company announced new pharmacokinetic and pharmacodynamic data from a preclinical study evaluating the oral delivery of the glucagon-like peptide-1 receptor agonist semaglutide administered via the RaniPill capsule.</li>
<li>Digital Turbine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPS#NASDAQ">APPS</a>) gained 28% to $3.25 in pre-market trading after the company reported better-than-expected third-quarter financial results and raised its FY25 sales guidance.</li>
<li>Digital Ally, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) gained 20.7% to $0.2560 in pre-market trading after gaining around 4% on Wednesday.</li>
<li>Moleculin Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) shares jumped 20% to $1.20 in pre-market trading after dipping 20% on Wednesday.</li>
<li>Silexion Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) gained 15.2% to $1.58 in pre-market trading after gaining 10% on Wednesday.</li>
<li>Recursion Pharmaceuticals, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) shares climbed 15% to $9.11 in pre-market trading after the company reported 12 month data from phase 2 study (Sycamore) of REC-994 at International Stroke Conference.</li>
<li>BigBear.ai Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) gained 10.3% to $7.84. BigBear.Ai shares jumped 45% on Wednesday after the company announced a contract by the DOD&#8217;s chief digital and artificial intelligence office.</li>
<li>Ginkgo Bioworks Holdings, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) gained 8.4% to $17.74 in pre-market trading after climbing over 14% on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Avinger, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares fell 29.4% to $0.3950 in pre-market trading.</li>
<li>Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) dipped 29.2% to $61.65 in pre-market trading after the company issued second-quarter adjusted EPS guidance below estimates..</li>
<li>FormFactor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) fell 27.7% to $29.78 in today's pre-market trading after the company reported worse-than-expected fourth-quarter adjusted EPS results and issued cirst-quarter guidance below estimates.</li>
<li>Matrix Service Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTRX#NASDAQ">MTRX</a>) shares fell 26.1% to $10.38 in pre-market trading after the company reported second-quarter financial results and cut its FY25 sales guidance below estimates.</li>
<li>Protagenic Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) shares tumbled 19.5% to $0.29 in pre-market trading following a 5% gain on Wednesday.</li>
<li>SunCar Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDA#NASDAQ">SDA</a>) fell 18.3% to $6.90 in pre-market trading after the company reported the pricing of $50 million follow-on public offering of class a ordinary shares.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) fell 16.6% to $25.80 in pre-market trading. Symbotic reported quarterly losses of three cents per share which missed the analyst consensus estimate for losses of two cents. Quarterly revenue of $486.69 million also missed the analyst consensus estimate of $490.98 million.</li>
<li>Universe Pharmaceuticals INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) fell 12.4% to $0.18 in pre-market trading after dipping 24% on Wednesday. Universe Pharmaceuticals recently announced a Nasdaq delisting notice.</li>
<li>Mach Natural Resources LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNR#NYSE">MNR</a>) declined 6.9% to $16.00 in pre-market trading as the company announced the launch of 12 million common unit offering.</li>
<li>Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) shares dipped 6.1% to $9.40 in pre-market trading. Ford reported upbeat fourth-quarter financial results on Wednesday. Ford said it sees full-year 2025 adjusted EBIT in a range of $7 billion to $8.5 billion, adjusted free cash flow in a range of $3.5 billion to $4.5 billion, and capital spending in a range of $8 billion to $9 billion.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43493237/jim-cramer-this-health-care-stock-is-a-winner-buy-bitcoin-instead-of-coinbase">Jim Cramer: This Health Care Stock Is A &#8216;Winner,&#8217; Buy Bitcoin Instead Of Coinbase</a></li>
</ul>

Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

FormFactor shares are trading lower after the company reported worse-than-expected Q4 adjusted EPS results and issued Q1 guidance below estimates.

B. Riley Securities analyst Craig Ellis downgrades FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) from Buy to Neutral and lowers the price target from $64 to $34.

B. Riley Securities Downgrades FormFactor to Neutral, Lowers Price Target to $34

FormFactor Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) shares are diving in extended trading Wednesday after the company reported fourth-quarter financial results that came up short <a href="https://www.benzinga.com/pressreleases/25/02/g43509179/formfactor-inc-reports-2024-fourth-quarter-results">of analyst expectations</a>.
<ul>
<li>Q4 Revenue: $189.48 million, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $191.12 million</li>
</ul>
<ul>
<li>Q4 Adjusted EPS: 27 cents, versus estimates of 29 cents</li>
</ul>
Total revenue was up 12.7% on a year-over-year basis. FormFactor said High Bandwidth Memory grew fourfold in fiscal 2024 compared to the prior year, driven by adoption of generative AI. DRAM probe-card revenue&nbsp;continued to climb in the quarter, reaching record levels for the third straight quarter.
&#8220;As expected, FormFactor reported sequentially lower fourth-quarter revenue, gross margin, and non-GAAP earnings per share, driven by the forecasted reduction in Foundry &amp; Logic probe-card revenue,&#8221; said Mike Slessor, CEO of FormFactor. &#8220;This was partially offset by growth in DRAM probe-card revenue, with HBM increasing to approximately half of DRAM revenue.&#8221;
FormFactor also announced that the company and MBK Partners are acquiring FICT Limited from Advantage Partners. FormFactor will invest $60 million and receive a 20% minority stake and a seat on the company&#8217;s board. 
&#8220;FormFactor&#8217;s investment in FICT builds on our long-term collaboration with them as a supplier of the industry-leading, high-performance components we use in our advanced probe cards, and provides a platform for accelerated development of tomorrow&#8217;s test and packaging consumables,&#8221; Slessor added.
See Also: <a href="https://www.benzinga.com/news/earnings/25/02/43511849/strategy-q4-earnings-bitcoin-treasury-company-spends-205b-on-btc-shares-inch-higher-despite-revenue-miss">Strategy Q4 Earnings: Bitcoin Treasury Company Spends $20.5B On BTC, Shares Inch Higher Despite Revenue Miss</a>
Outlook: FormFactor expects first-quarter revenue to be in the range of $165 million to $175 million versus estimates of $195.81 million. The company anticipates first-quarter adjusted earnings of 3 cents to 11 cents per share, versus estimates of 33 cents per share. 
FormFactor noted it has continued to see &#8220;slow demand&#8221; in high-volume markets like client PCs and mobile handsets in the first quarter. Despite the slowing demand, the company anticipates an overall demand increase for its products throughout 2025.
FORM Price Action: FormFactor shares were down 22.81% after hours, trading at $31.74 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
This illustration was generated using AI from MidJourney.

Earnings

Guidance

After-Hours Center

FormFactor Stock Falls On Q4 Earnings Miss, Weak Guidance As 'Slow Demand' Continues In Q1

FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) announced its Q4 earnings on Wednesday, February 5, 2025 at 04:01 PM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
FormFactor missed estimated earnings by -7.000000000000001%, reporting an EPS of $0.27 versus an estimate of $0.29.
Revenue was up $21.32 million from the same period last year.
<h3>Overview of Past Earnings</h3>
During the previous quarter, the company beat on EPS by $0.04, leading to a 13.0% drop share price change the next day.
Here's a look at FormFactor's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.31</td>
<td>0.31</td>
<td>0.19</td>
<td>0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.35</td>
<td>0.35</td>
<td>0.18</td>
<td>0.20</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>200.29M</td>
<td>194.99M</td>
<td>165.27M</td>
<td>165.29M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>207.92M</td>
<td>197.47M</td>
<td>168.72M</td>
<td>168.16M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
FormFactor management provided guidance for Q1 2025, expecting earnings between $0.03 and $0.11 per share.
To track all earnings releases for FormFactor <a href="https://www.benzinga.com/quote/FORM/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FormFactor Q4 Earnings Assessment

FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) announced its Q4 earnings on Wednesday, February 5, 2025 at 04:01 PM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
FormFactor missed estimated earnings by -7.000000000000001%, reporting an EPS of $0.27 versus an estimate of $0.29.
Revenue was up $21.32 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
The company beat on EPS by $0.04 in the previous quarter, leading to a 13.0% drop share price change the next day.
Here's a look at FormFactor's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.31</td>
<td>0.31</td>
<td>0.19</td>
<td>0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.35</td>
<td>0.35</td>
<td>0.18</td>
<td>0.20</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>200.29M</td>
<td>194.99M</td>
<td>165.27M</td>
<td>165.29M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>207.92M</td>
<td>197.47M</td>
<td>168.72M</td>
<td>168.16M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
FormFactor management provided guidance for Q1 2025, expecting earnings between $0.03 and $0.11 per share.
To track all earnings releases for FormFactor <a href="https://www.benzinga.com/quote/FORM/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FormFactor Q4 Earnings Summary & Key Takeaways

The Q4 earnings report for FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) was released on Wednesday, February 5, 2025 at 04:01 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
FormFactor missed estimated earnings by -7.000000000000001%, reporting an EPS of $0.27 versus an estimate of $0.29.
Revenue was up $21.32 million from the same period last year.
<h3>Past Earnings Performance</h3>
During the previous quarter, the company beat on EPS by $0.04, leading to a 13.0% drop share price change the next day.
Here's a look at FormFactor's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.31</td>
<td>0.31</td>
<td>0.19</td>
<td>0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.35</td>
<td>0.35</td>
<td>0.18</td>
<td>0.20</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>200.29M</td>
<td>194.99M</td>
<td>165.27M</td>
<td>165.29M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>207.92M</td>
<td>197.47M</td>
<td>168.72M</td>
<td>168.16M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
FormFactor management provided guidance for Q1 2025, expecting earnings between $0.03 and $0.11 per share.
To track all earnings releases for FormFactor <a href="https://www.benzinga.com/quote/FORM/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Breakdown: FormFactor Q4

The earnings results for FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) for Q4 were made public on Wednesday, February 5, 2025 at 04:01 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
FormFactor missed estimated earnings by -7.000000000000001%, reporting an EPS of $0.27 versus an estimate of $0.29.
Revenue was up $21.32 million from the same period last year.
<h3>Historical Earnings Summary</h3>
In the previous quarter, the company beat on EPS by $0.04, resulting in a 13.0% drop change in the share price the following day.
Here's a look at FormFactor's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.31</td>
<td>0.31</td>
<td>0.19</td>
<td>0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.35</td>
<td>0.35</td>
<td>0.18</td>
<td>0.20</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>200.29M</td>
<td>194.99M</td>
<td>165.27M</td>
<td>165.29M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>207.92M</td>
<td>197.47M</td>
<td>168.72M</td>
<td>168.16M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
FormFactor management provided guidance for Q1 2025, expecting earnings between $0.03 and $0.11 per share.
To track all earnings releases for FormFactor <a href="https://www.benzinga.com/quote/FORM/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FormFactor Q4 Earnings Report: What Investors Need to Know

Press Releases

General

FormFactor and Advantest Partner on Silicon Photonics Wafer-Level Test Cell to Enable High-Volume Manufacturing

FormFactor Receives SK hynix Best Partner Award

FormFactor Announces Participation at Upcoming Conference

FormFactor Announces Participation in 13th Annual NYC Summit

FormFactor Inc. To Present At The 27th Annual Needham Growth Conference

FormFactor Expands Partnership with Advantest

FormFactor to Announce Fourth Quarter 2024 Financial Results on February 5th

FormFactor, Inc. Reports 2024 Fourth Quarter Results

FormFactor Announces the Closing of FICT Transaction

FormFactor Partners with Delft Circuits to Revolutionize Quantum Computing Interfacing

Axcelis Technologies, Inc. - Common Stock

Axcelis Technologies

ACM Research, Inc. - Class A Common Stock

ACM Research

Aehr Test System

Applied Mat

Amkor Tech

ASML Holding N.V. - New York Registry Shares

ASML Holding

Amtech Systems

Atomera

Cohu

DAQO New Energy Corp. American Depositary Shares, each representing five ordinary shares

Comments

FormFactor

FormFactor (FORM) Opciones

FormFactor (NASDAQ:FORM) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL